The Covid vaccine administration programme for children aged 12 to 14 years old began in Telangana on Wednesday, with Health Minister T Harish Rao initiating the effort at the Community Health Centre (CHC), Khairatabad.
The Telangana Health Department will deliver the Corbevax Covid vaccine, which is made by Hyderabad-based Biological E Limited and designed by researchers in Texas, United States, to nearly 17 lakh eligible youngsters aged 12 to 14 years.
I advise parents not to miss out on this fantastic opportunity to receive free Covid immunizations at all government health care facilities. Please do not get distracted because the Covid third wave was not as severe. We have no idea what shape the coronavirus will take in the following months. It’s always better to be safe than sorry. As a result, I urge parents to make the correct decision and get their children vaccinated as soon as possible,” Harish Rao said at the start of the Covid vaccination drive.
ALSO READ: Vaccination for 12-14 Years Age Group to Begin Wednesday: Centre
Parents can either arrange a slot online or stroll into the nearest government healthcare institution with their children for spot registration to receive the Covid vaccine. MLA Danam Nagender, Minister Talasani Srinivas Yadav, and other local public representatives attended the Covid immunisation drive’s opening session.
“All required precautions have been taken to assure safe immunisation for children aged 12 to 14 across the state.” They will get immunised in front of their parents. “Vaccination for children aged 12 to 14 years will begin on March 16 across the state,” said Dr G Srinivasa Rao, Telangana state director of public health.
According to the most recent data, a total of 5.94 crore Covid vaccination doses have been delivered in the state.
The first dosage coverage for people aged 18 and up is 106% of the target population, while the second dose coverage is 97%.
The first dose is covered by 86% of the 15-17-year-old age group, while the second dose is covered by 60%.
Currently, 36% of precaution doses are covered.
(This story has been sourced from a third-party syndicated feed, agencies. Raavi Media accepts no responsibility or liability for the dependability, trustworthiness, reliability, and data of the text. Raavi Media management/ythisnews.com reserves the sole right to alter, delete or remove (without notice) the content at its absolute discretion for any reason whatsoever.)
